| 000 | 01542 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513192204.0 | ||
| 264 | 0 | _c20000113 | |
| 008 | 200001s 0 0 fre d | ||
| 022 | _a0248-8663 | ||
| 024 | 7 |
_a10.1016/s0248-8663(99)80511-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBlicklé, J F | |
| 245 | 0 | 0 |
_a[Current status of the treatment of type 2 diabetes mellitus. Alpha-glucosidase inhibitors]. _h[electronic resource] |
| 260 |
_bLa Revue de medecine interne _cAug 1999 |
||
| 300 |
_a379s-383s p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article; Review | ||
| 650 | 0 | 4 |
_a1-Deoxynojirimycin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAcarbose _xtherapeutic use |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 |
_aDietary Carbohydrates _xmetabolism |
| 650 | 0 | 4 |
_aDisaccharides _xmetabolism |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aGlucosamine _xanalogs & derivatives |
| 650 | 0 | 4 | _aGlycoside Hydrolase Inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrolysis _xdrug effects |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aImino Pyranoses |
| 650 | 0 | 4 |
_aInsulin _xtherapeutic use |
| 650 | 0 | 4 |
_aPolysaccharides _xmetabolism |
| 700 | 1 | _aAndres, E | |
| 700 | 1 | _aBrogard, J M | |
| 773 | 0 |
_tLa Revue de medecine interne _gvol. 20 Suppl 3 _gp. 379s-383s |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0248-8663(99)80511-6 _zAvailable from publisher's website |
| 999 |
_c10437590 _d10437590 |
||